首页GRAL • NASDAQ
add
Grail Inc
昨日收盘价
$16.38
当日价格范围
$15.96 - $16.63
年度波幅
$13.41 - $21.47
市值
5.55亿 USD
平均交易量
59.92万
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 2865.20万 | 38.27% |
经营支出 | 1.76亿 | -12.27% |
净收入 | -1.26亿 | 85.90% |
净利润率 | -438.67 | 89.80% |
每股收益 | -3.50 | — |
息税折旧摊销前利润 | -1.25亿 | 18.72% |
有效税率 | 27.10% | — |
资产负债表
总资产
负债总额
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 8.54亿 | — |
总资产 | 31.18亿 | — |
负债总额 | 5.30亿 | — |
权益总额 | 25.88亿 | — |
发行在外的股份 | 3360.08万 | — |
市净率 | 0.21 | — |
资产回报率 | -12.88% | — |
资本回报率 | -15.14% | — |
现金流
现金净变动
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | -1.26亿 | 85.90% |
来自运营的现金 | -1.05亿 | 33.60% |
投资现金 | -97.10万 | 68.36% |
融资现金 | 0.00 | -100.00% |
现金净变动 | -1.05亿 | -21.33% |
自由现金流 | -3690.15万 | — |
简介
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
Grail was spun-out from Illumina on June 24, 2024.
Their liquid biopsy was launched in June 2021 and is called the Galleri test. Promoted as groundbreaking, the test performed poorly in testing and Grail has subsequently faced discontent and legal action from investors claiming they have been misled about the test's potential. Wikipedia
成立时间
2015
员工数量
1,170